E-LIB Suche - Ergebnisse für: Braña, I

1

99P Molecular correlates and treatment outcomes of patients..:

Pretelli, G. ; Laimito, K.I. Rojas ; Casal, G. Alonso...
ESMO Open. 9 (2024) - p. 102325 , 2024

Link: https://doi.org/10.1016/..

2

93P Evolving landscape of targeted therapies (TT) in early ..:

Rossi, A. ; Braña, I. ; Villar, M. Vieito...
ESMO Open. 9 (2024) - p. 102319 , 2024

Link: https://doi.org/10.1016/..

3

VP5-2024: Eftilagimod alpha (soluble LAG-3) and pembrolizum..:

Metcalf, R. ; Laban, S. ; Kristensen, C.A....
Annals of Oncology. 35 (2024) 8 - p. 754-755 , 2024

Link: https://doi.org/10.1016/..

4

29O Clinical characterization of long-term survivors in pha..:

Mirallas, O. ; Rossi, A. ; Fernández, E.M....
ESMO Open. 9 (2024) - p. 102357 , 2024

Link: https://doi.org/10.1016/..

5

51P Toxicity profile in early clinical trials with fibrobla..:

Rojas Laimito, K.I. ; Vieito Villar, M. ; Fullana Grimalt, B....
ESMO Open. 8 (2023) 1 - p. 100909 , 2023

Link: https://doi.org/10.1016/..

6

PO-1203 Reirradiation in head and neck cancer. Who would be..:

Granado, R. ; Pires, F. ; Benavente, S....
Radiotherapy and Oncology. 182 (2023) - p. S962-S963 , 2023

Link: https://doi.org/10.1016/..

7

77P Impact of germline HLA genotypes on clinical outcomes i..:

Vieito Villar, M. ; Rojas Laimito, K.I. ; López, D....
ESMO Open. 8 (2023) 1 - p. 100935 , 2023

Link: https://doi.org/10.1016/..

8

106P Treatment sequencing in PD-L1–positive recurrent/metas..:

Greil, R. ; Burtness, B. ; Laban, S....
Immuno-Oncology and Technology. 20 (2023) - p. 100578 , 2023

Link: https://doi.org/10.1016/..

9

Transition to the new EU CTIS Portal for Regulatory Clinica..:

Matres, A. ; Carballo, N. ; Bernabé, Y....
European Journal of Cancer. 174 (2022) - p. S48 , 2022

Link: https://doi.org/10.1016/..

10

Lurbinectedin, a selective inhibitor of oncogenic transcrip..:

Boni, V. ; Pistilli, B. ; Braña, I....
ESMO Open. 7 (2022) 5 - p. 100571 , 2022

Link: https://doi.org/10.1016/..

11

Representation of young adult(19–29 y) and elderly(>75 y) p..:

Vieito Villar, M. ; Rojas, K. ; Roger, B....
European Journal of Cancer. 174 (2022) - p. S49-S50 , 2022

Link: https://doi.org/10.1016/..

12

196TiP A phase I study of REGN6569, a GITR monoclonal antib..:

Lakhani, N. ; Hamid, O. ; Braña, I....
Immuno-Oncology and Technology. 16 (2022) - p. 100308 , 2022

Link: https://doi.org/10.1016/..

13

Non-invasive biomarkers for response and survival predictio..:

Bernatowicz, K. ; Vieito, M. ; Berche, R....
European Journal of Cancer. 174 (2022) - p. S70 , 2022

Link: https://doi.org/10.1016/..

14

Phase I, first-in-human study of MSC-1 (AZD0171), a humaniz..:

Borazanci, E. ; Schram, A.M. ; Garralda, E....
ESMO Open. 7 (2022) 4 - p. 100530 , 2022

Link: https://doi.org/10.1016/..

15

OC-0515 NBTXR3 activated by radiotherapy in cisplatin-ineli..:

Le Tourneau, C. ; Calugaru, V. ; Takacsi-Nagy, Z....
Radiotherapy and Oncology. 161 (2021) - p. S399 , 2021

Link: https://doi.org/10.1016/..